TABLE 3

Pharmacokinetic parameters for APD791 and its metabolites, and the sum of APD791 and its metabolites after oral administration of APD791 at 10 mg/kg in male beagle dogs

ParameterAPD791aAPD791-M1bAPD791-M2bTotalc
t1/2(h)0.94 ± 0.045.112.55.7
tmax(h)0.3 ± 0.10.52.00.3
Cmax (μg/ml)2.28 ± 0.320.3360.01542.45
AUC0-inf (hr·μg/ml)3.55 ± 0.772.210.2725.84
  • a Values were determined from individual animal plasma concentration (nanogram equivalents of APD791·HCl) versus time profiles (mean ± S.D., n = 3).

  • b Values were determined from pooled plasma concentration (nanogram equivalents of APD791·HCl) versus time profiles.

  • c Values were determined from the sum of the plasma concentrations of APD791, M1, and M2 (nanogram equivalents of APD791·HCl) versus time profiles.